Navigation Links
U of M researchers discover link between heart, blood, and skeletal muscle
Date:5/2/2013

MINNEAPOLIS/ST. PAUL (MAY 2, 2013) New research out of the Lillehei Heart Institute at the University of Minnesota shows that by turning on just a single gene, Mesp1, different cell types including the heart, blood and muscle can be created from stem cells.

The study was published today in the journal Cell Stem Cell.

"Previous research indicated that this gene was the "master regulator" for development of the heart, and that its activity prevented the differentiation of other cell types," said Michael Kyba, Ph.D., associate professor in the University of Minnesota Medical School Department of Pediatrics and a Lillehei endowed scholar. "Our work reveals that this gene acts differently, and that it plays a role in the development of blood and skeletal muscle as well. The outcome depends on the chemical signals that cells expressing this factor sense in their environment."

The research was conducted in the Kyba Lab by lead author Sunny Chan, Ph.D., a postdoctoral associate in the lab.

Stem cell researchers have been trying to generate different cell types for regenerative medicine for years. The gene Mesp1 was particularly interesting to cardiac researchers because it was believed to be a master regulator, sitting at the pinnacle of a gene hierarchy driving cardiac differentiation, blocking the differentiation of other cell types.

However, this research turns that assumption on its head.

A carefully designed study, aimed at understanding precisely what Mesp1 does at different points in time as stem cells develop, revealed that the gene can do so much more than previously thought.

By turning Mesp1 on and off at specific time windows and fine-tuning the culture environment, stem cells can be coached to become not just heart cells, but also blood and muscle cells.

"This is totally out of the blue, but our discovery brings some conflicting findings about Mesp1 together," said Chan. "Some previous studies reported Mesp1 could not make heart cells in certain contexts. We now know why."

The Kyba team further shows Mesp1 is present in the cells that go on to become adult stem cells in the bone marrow which form new blood cells, and stem cells in the skeletal muscles, which form new muscle fibers.

"We are amazed at what a single gene can do," said Chan. "By understanding what Mesp1 does, we are more likely to make different cell types from stem cells more efficiently. We are one step closer to using stem cell technology for regenerative medicine."


'/>"/>

Contact: Caroline Marin
crmarin@umn.edu
612-624-5680
University of Minnesota Academic Health Center
Source:Eurekalert

Related medicine news :

1. Researchers determine where best to place defibrillators
2. Researchers plot locations where AEDs could save more lives
3. Gene Mutation Linked to Migraines, Researchers Say
4. Discovery of New Cause of Congenital Hydrocephalus Opens the Door to Collaborative Research Study, Hydrocephalus Association Commends Researchers
5. Northwestern Medicine researchers work to improve heart attack response time
6. NYU and NYU Langone researchers devise method for enhancing CEST MRI
7. Medicaid-insured children have limited access to dermatologists, SLU researchers find
8. Federally funded research & development centers employed more than 3,000 postdoctoral researchers
9. 5 honored with AcademyHealth Presidential Scholarship for New Health Services Researchers
10. Researchers observe an increased risk of cancer in people with history of non-melanoma skin cancer
11. Researchers identify new pathway, enhancing tamoxifen to tame aggressive breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... While it’s ... poses a problem. Fortunately, an inventor from Austin, Texas, has identified a solution. , ... medication in darkness or restricted lighting. As such, it eliminates the need to turn ...
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... Shelton, CT (PRWEB) , ... October 13, 2017 , ... ... and long-term care services, staged a mock evacuation of the facility as part of ... Department, Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
(Date:9/12/2017)... PARIS and NEW YORK , Sept. 12, ... ethical performance ratings for global supply chains, has published the first annual ... the CSR performance of more than 20,400 companies evaluated by EcoVadis, based ... years 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology: